Tag: CLI

Lack of access to vascular specialists creates major disparities in amputation...

Speaking on current trends in amputation rates with critical limb-threatening ischaemia (CLTI) patients, Misty Humphries (Sacramento, USA) tells Vascular News that while Medicare data shows that amputation rates...
CLTI

New tools for CLTI: ISET audience hear what’s on the horizon...

“I am going to give you reasons to be excited about your critical limb practice,” Peter Schneider (University of California San Francisco, San Francisco,...
FlowOx

Novel PAD treatment may be more cost-effective than standard care, study...

FlowOx therapy (Otivio) delivered as a single annual dose may be a cost-effective treatment for peripheral arterial disease (PAD), a recent study published in...
journal

The CLI Global Society announces the Journal of Critical Limb Ischemia

The CLI Global Society is launching the first peer-reviewed academic journal focusing on interventional techniques pertaining to critical limb ischemia (CLI). The new journal,...
PROMISE

LINC 2021: New data show potential of Limflow system to improve...

In a late-breaking trial session at LINC 2021 (The Leipzig Interventional Course, 25–29 January, online), key updates on below-the-knee (BTK) interventions were in the spotlight. Speaking during his...

CDC recognises and codifies critical limb-threatening ischaemia in ICD-10-CM

A coalition organised by the CLI Global Society has announced its proposal to distinctly recognise "critical limb ischaemia" (CLI) and "chronic limb-threatening ischaemia" (CLTI)...
pedal

Pedal artery revascularisation: Is it ready for prime time?

Reviewing the available evidence for below-the-ankle interventions in the treatment of critical limb-threatening ischaemia (CLTI), Srini Tummala proposes that pedal artery intervention “should be...

First US commercial use of Tack Endovascular System (4F) in BTK...

Intact Vascular has announced the first commercial use of its Tack Endovascular System (4F) in multiple sites across the USA. Notably the first FDA-approved...

LINC 2020: Profusa Lumee oxygen platform may improve clinical management of...

Profusa has announced research findings that suggest the company's Lumee oxygen platform may help improve the clinical management of patients with critical limb ischaemia...
Wireless Lumee Oxygen

Profusa wins CE mark approval for real-time tissue oxygen monitoring platform

Profusa has announced that it has received Conformité Européenne (CE) mark approval to market its Wireless Lumee Oxygen platform for continuous, real-time monitoring of...
Regentec clinical trial

First patient enrolled in Cook Regentec’s clinical trial of investigational therapy...

Cook Regentec has announced enrolment of the first patient in an international clinical trial evaluating the HemaTrate Blood Filtration System to treat patients with...
katherine-leckie-critical-limb-ischaemia

Cell therapy may provide benefit for “no option” critical limb ischaemia...

Two-year results from the MOBILE (Marrowstim treatment of limb ischaemia in patients with severe peripheral arterial disease) trial indicate that injecting concentrated bone marrow...

Intraoperative oxygen monitoring predicts wound healing in critical limb ischaemia patients...

Preliminary findings from an initial study with 25 patients have shown that measuring the changes in oxygen concentration at baseline, during, and after endovascular...